256 related articles for article (PubMed ID: 26234693)
1. Agreement of site and central readings of ileocolonoscopic scores in Crohn's disease: comparison using data from the EXTEND trial.
Rutgeerts P; Reinisch W; Colombel JF; Sandborn WJ; D'Haens G; Petersson J; Zhou Q; Iezzi A; Thakkar RB
Gastrointest Endosc; 2016 Jan; 83(1):188-97.e1-3. PubMed ID: 26234693
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
[TBL] [Abstract][Full Text] [Related]
3. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
[TBL] [Abstract][Full Text] [Related]
4. Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.
Khanna R; Zou G; Stitt L; Feagan BG; Sandborn WJ; Rutgeerts P; McDonald JWD; Dubcenco E; Fogel R; Panaccione R; Jairath V; Nelson S; Shackelton LM; Huang B; Zhou Q; Robinson AM; Levesque BG; D'Haens G
Am J Gastroenterol; 2017 Oct; 112(10):1584-1592. PubMed ID: 28071654
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND Trial.
Reinisch W; Colombel JF; D'Haens G; Sandborn WJ; Rutgeerts P; Geboes K; Petersson J; Eichner S; Zhou Q; Robinson AM; Read HA; Thakkar R
J Crohns Colitis; 2017 Apr; 11(4):425-434. PubMed ID: 27815351
[TBL] [Abstract][Full Text] [Related]
6. Effect of Standardised Scoring Conventions on Inter-rater Reliability in the Endoscopic Evaluation of Crohn's Disease.
Dubcenco E; Zou G; Stitt L; Baker JP; Jeejeebhoy KN; Kandel G; Kim YI; Grover SC; McDonald JW; Shackelton LM; Khanna R; D'Haens G; Sandborn WJ; Feagan BG; Levesque BG
J Crohns Colitis; 2016 Sep; 10(9):1006-14. PubMed ID: 27385400
[TBL] [Abstract][Full Text] [Related]
7. Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease.
Khanna R; Zou G; D'Haens G; Rutgeerts P; McDonald JW; Daperno M; Feagan BG; Sandborn WJ; Dubcenco E; Stitt L; Vandervoort MK; Donner A; Luo A; Levesque BG
Gut; 2016 Jul; 65(7):1119-25. PubMed ID: 25935574
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic scoring indices for evaluation of disease activity in Crohn's disease.
Khanna R; Nelson SA; Feagan BG; D'Haens G; Sandborn WJ; Zou GY; MacDonald JK; Parker CE; Jairath V; Levesque BG
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010642. PubMed ID: 27501379
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic evaluation of Crohn's disease activity: comparison of the CDEIS and the SES-CD.
Sipponen T; Nuutinen H; Turunen U; Färkkilä M
Inflamm Bowel Dis; 2010 Dec; 16(12):2131-6. PubMed ID: 20848462
[TBL] [Abstract][Full Text] [Related]
10. Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX.
Rivière P; D'Haens G; Peyrin-Biroulet L; Baert F; Lambrecht G; Pariente B; Bossuyt P; Buisson A; Oldenburg B; Vermeire S; Laharie D
Am J Gastroenterol; 2021 Jan; 116(1):134-141. PubMed ID: 33177349
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted magnetic resonance imaging is effective to detect ileocolonic ulcerations in Crohn's disease.
Buisson A; Hordonneau C; Goutte M; Boyer L; Pereira B; Bommelaer G
Aliment Pharmacol Ther; 2015 Aug; 42(4):452-60. PubMed ID: 26088810
[TBL] [Abstract][Full Text] [Related]
12. Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD).
Daperno M; Comberlato M; Bossa F; Biancone L; Bonanomi AG; Cassinotti A; Cosintino R; Lombardi G; Mangiarotti R; Papa A; Pica R; Rizzello F; D'Incà R; Orlando A
Dig Liver Dis; 2014 Nov; 46(11):969-73. PubMed ID: 25154049
[TBL] [Abstract][Full Text] [Related]
13. Colon Capsule Endoscopy in the Assessment of Mucosal Healing in Crohn's Disease.
Papalia I; Tjandra D; Quah S; Tan C; Gorelik A; Sivanesan S; Macrae F
Inflamm Bowel Dis; 2021 Nov; 27(Supplement_2):S25-S32. PubMed ID: 34791289
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn's disease.
Alfaro I; Masamunt MC; Planell N; López-García A; Castro J; Gallego M; Barastegui R; Giner A; Vara A; Salas A; Ricart E; Panés J; Ordás I
World J Gastroenterol; 2019 Apr; 25(14):1764-1774. PubMed ID: 31011260
[TBL] [Abstract][Full Text] [Related]
15. Safety and Feasibility of Using the Second-Generation Pillcam Colon Capsule to Assess Active Colonic Crohn's Disease.
D'Haens G; Löwenberg M; Samaan MA; Franchimont D; Ponsioen C; van den Brink GR; Fockens P; Bossuyt P; Amininejad L; Rajamannar G; Lensink EM; Van Gossum AM
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1480-6.e3. PubMed ID: 25804331
[TBL] [Abstract][Full Text] [Related]
16. Editorial: Endoscopic Scoring Systems in Crohn's Disease for Evaluation of Responsiveness to Treatment: Are we Ready for the Prime Time of Endoscopic Assessment?
Buchner AM; Lichtenstein GR
Am J Gastroenterol; 2017 Oct; 112(10):1593-1595. PubMed ID: 28978952
[TBL] [Abstract][Full Text] [Related]
17. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
Rutgeerts P; Diamond RH; Bala M; Olson A; Lichtenstein GR; Bao W; Patel K; Wolf DC; Safdi M; Colombel JF; Lashner B; Hanauer SB
Gastrointest Endosc; 2006 Mar; 63(3):433-42; quiz 464. PubMed ID: 16500392
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol.
Hébuterne X; Lémann M; Bouhnik Y; Dewit O; Dupas JL; Mross M; D'Haens G; Mitchev K; Ernault É; Vermeire S; Brixi-Benmansour H; Moreels TG; Mary JY; Marteau P; Colombel JF
Gut; 2013 Feb; 62(2):201-8. PubMed ID: 22525883
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.
Daperno M; D'Haens G; Van Assche G; Baert F; Bulois P; Maunoury V; Sostegni R; Rocca R; Pera A; Gevers A; Mary JY; Colombel JF; Rutgeerts P
Gastrointest Endosc; 2004 Oct; 60(4):505-12. PubMed ID: 15472670
[TBL] [Abstract][Full Text] [Related]
20. Impact of disease location on fecal calprotectin levels in Crohn's disease.
Gecse KB; Brandse JF; van Wilpe S; Löwenberg M; Ponsioen C; van den Brink G; D'Haens G
Scand J Gastroenterol; 2015 Jul; 50(7):841-7. PubMed ID: 25636819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
